Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Staying transaction-ready in uncertain market conditions
Editor’s note: The perspectives expressed in this commentary are the author’s alone. The following is a paid thought leadership piece from The Ferguson Smith Cohen Group at Morgan Stanley. In the face of market uncertainty, one thing private companies can control is their “transaction-readiness” for an IPO or secondary offering. Discover three things a company…
Zee underscores artists’ need for positive venues; creative powerhouse opens pocket of support
Zahra Briggs developed her creative voice in Kansas City; now she’s setting the stage for fellow independent artists who struggle to find venues that match their vibe — and often have to pay to perform. She’s even creating a version of herself in the metaverse to open access further. A singer and songwriter herself, Briggs — who…
MyAnIML earns NSF funding, patent; now facing new phase of growth with industry validation
Thanks to a recent federal grant — along with a newly secured patent on its first-of-its-kind, proprietary facial recognition tech for cows — MyAnIML is proving its place as a leader within a herd of ag innovation, Shekhar Gupta said. The Overland Park startup received a 250,000 Phase I grant from the National Science Foundation…
KC’s next LGBTQ+ space wants to be more than just a raging club; How this permanent takeover aims to better reflect queer nightlife
Westport nightlife is set for transformation as a sweeping expansion adds seven late-night hotspots to the historic entertainment district — anchored by a new bar catering specifically to Kansas City’s LGBTQ+ community. Q Kansas City — a collaboration with Lance Pierce of Queer Bar Takeover — is expected open its doors in October at 504 Westport…